Resources from the same session
Introduction
Presenter: Rebecca Dent
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Neoadjuvant vs adjuvant approaches in early TNBC
Presenter: Javier Cortés
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
DNA damaging agents and PARP inhibitors
Presenter: Veronique Dieras
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Should we incorporate immunotherapy in early breast cancer?
Presenter: Rebecca Dent
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Future directions in TNBC early breast cancer trials
Presenter: Sibylle Loibl
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Veronique Dieras
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast